CatalystAlert

Search CatalystAlert

Search for companies, drugs, and catalysts

Search CatalystAlert

Search for companies, drugs, and catalysts

Back to GENK

SUL-238 (1500 mg t.i.d.) film-coated tablets

Phase 2
GEN Restaurant Group, Inc. (GENK)

Phase 2

Development Phase

0

Upcoming Catalysts

0

Historical Events

0

Regulatory Approvals

No Catalysts Found

No catalyst events have been recorded for this drug yet.

Competitive Landscape

0 competitors in Parkinson's Disease (PD)

View Full Landscape
Drug Information

Target Indication

Parkinson's Disease (PD)

Clinical Trial

NCT07322887

Last updated: 4/1/2026

Patent & Exclusivity

No patent data available. Pre-approval drugs may not have Orange Book listings.

Drug Science
Mechanism of action & safety profile
Get Catalyst Alerts
Receive weekly digests of upcoming catalysts

Weekly digest every Monday. Unsubscribe anytime.